As part of our regular internal legal seminars, Dr. Wilhelm Eger held a talk on current developments in infringement under the doctrine of equivalency in various European lega...
Continue reading
In addition to the pharmaceutical strategy for Europe[1], the European Commission adopted a new action plan for intellectual prop...
Continue reading
In addition to the Pharmaceutical strategy for Europe[1], the European Commission adopted a new Action Plan for Intellectual Prop...
Continue reading
All articles
The article sheds light on preliminary injunction proceedings before the local division of the Unified Patent Court (UPC) in Munich between the applicant Tiroler Rohre (TRM) and the defendants SSAB Swedish Steel GmbH and SSAB Europe Oy concerning pile shoes for anchoring str...
Continue reading
In the ongoing case between Sanofi and the generic drug manufacturer Accord, the Paris Judicial Court has fully revoked Sanofi’s patent for the chemotherapy drug Jevtana. The patent EP 2 493 466, which protects a new use of cabazitaxel in combination with prednisone or pre...
Continue reading
Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK, NY and SOUTH SAN FRANCISCO, CA, May 22, 2024 – Royalty Phar...
Continue reading
Maiwald in the press
Maiwald, one of Germany's leading intellectual property law firms, has appointed Dr. Gisela Gerstberger as partner with effect from October 1, 2024, thereby expanding its grow...
Continue reading
We are very pleased to congratulate
Continue reading
Staff News
This year, IAM has once again invited leading experts in the field of intellectual property to provide valuable insights, highlight key experiences and share their views on th...
Continue reading
Dr. Christian Meyer and Dr. Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for m...
Continue reading
We can now look back on a quite successful first year of the new European patent and court system. Now well into its second year, the Unitary Patent (UP) continues to grow in ...
Continue reading
All publications
At Maiwald, we go to great lengths to ensure that all our colleagues feel comfortable and are constantly trying to optimize ourselves in order to achieve and maintain the most...
Continue reading
We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders: Dr. Andreas Ledl...
Continue reading
JUVE Patent published the new JUVE Patent Germany ranking 2024 – and our firm is not only recommended in the category “Patent Filing” but also in “
Continue reading
All awards
Mon.
20
We're excited to be a Platinum Partner to the 4th Annual Pharma & Biotech Patent Litigation Europe! Don't miss the Co-Chairs' Opening Remarks with our partner
Continue reading
Thu.
28
as part of the 44th Patent and Trademark FORUM 2024 The PatentFORUM is your opportunity to exchange ideas with your colleagues at a high level and to keep up to date with the latest developments in patent law.
Continue reading
Wed.
27
The conference will once again offer IP professionals a top-class programme - with more than twenty lecturers and specialist topics, a balanced combination of workshops and lectures on the latest developments and case law in national and international patent, trademark and design law. Our colleague
Continue reading
Wed.
27
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich
Continue reading
All events